Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000470160 | SCV000559893 | benign | Adams-Oliver syndrome 5 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000121699 | SCV000714894 | benign | not specified | 2017-01-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000769587 | SCV000738380 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769587 | SCV000900984 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-08-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000470160 | SCV002553855 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269865 | SCV002553856 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000121699 | SCV004029557 | likely benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004717992 | SCV005323729 | benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000121699 | SCV000085897 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Laboratory of Diagnostic Genome Analysis, |
RCV000121699 | SCV001800371 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000121699 | SCV001806917 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000121699 | SCV001964856 | benign | not specified | no assertion criteria provided | clinical testing |